Melding biology and physical sciences yields deeper understanding of cancer

BOSTON – An evolving understanding of cancer that incorporates the physical properties of tumors and their surrounding tissues into existing biologic and genetic models can direct cancer researchers down previously uncharted avenues, potentially leading to new drugs and new treatment strategies, say investigators from Massachusetts General Hospital (MGH), Harvard Medical School (HMS) and the Ludwig…

For Black LGBQ+ Americans, intersectional experiences can hurt — or help, YSPH study finds

For Black LGBQ+ Americans, Intersectional Experiences Can Hurt — Or Help, YSPH Study FindsUsing a new method for quantifying intersectional experiences, a new Yale School of Public Health study finds that Black LGBQ+ Americans tend to feel better about themselves after encountering events that affirm their identity. In the study, which was recently published in…

Petricoin receives funding for study focused on discovering cancer protein biomarkers

Emanuel Petricoin, III, Co-Director, Center for Applied Proteomics and Molecular Medicine (CAPMM), received $280,696 from Gateway for Cancer Research for: “Discovery of Protein Biomarkers for Response Prediction to Novel Phase II Targeted Therapy Agents for Stage II/III Breast Cancer Patients in the ISPY2 TRIAL.” This funding began in October 2020 and will end in late…

New drug candidate for the treatment of COVID-19

Researchers from the University of Kent, the Goethe-University in Frankfurt am Main (Germany), and the Hannover Medical School (Germany) have identified a drug with the potential to provide a treatment for COVID-19. The international team led by Professor Martin Michaelis, Dr Mark Wass (both School of Biosciences, University of Kent), and Professor Jindrich Cinatl (Institute…